CD36 配体通过组装 Toll 样受体 4 和 6 异源二聚体促进无菌性炎症。

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.

机构信息

Lipid Metabolism Unit, Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Nat Immunol. 2010 Feb;11(2):155-61. doi: 10.1038/ni.1836. Epub 2009 Dec 27.

Abstract

In atherosclerosis and Alzheimer's disease, deposition of the altered self components oxidized low-density lipoprotein (LDL) and amyloid-beta triggers a protracted sterile inflammatory response. Although chronic stimulation of the innate immune system is believed to underlie the pathology of these diseases, the molecular mechanisms of activation remain unclear. Here we show that oxidized LDL and amyloid-beta trigger inflammatory signaling through a heterodimer of Toll-like receptors 4 and 6. Assembly of this newly identified heterodimer is regulated by signals from the scavenger receptor CD36, a common receptor for these disparate ligands. Our results identify CD36-TLR4-TLR6 activation as a common molecular mechanism by which atherogenic lipids and amyloid-beta stimulate sterile inflammation and suggest a new model of TLR heterodimerization triggered by coreceptor signaling events.

摘要

在动脉粥样硬化和阿尔茨海默病中,自身改变成分氧化的低密度脂蛋白(LDL)和淀粉样β的沉积引发了一种持续的无菌性炎症反应。虽然人们认为固有免疫系统的慢性刺激是这些疾病发病机制的基础,但激活的分子机制仍不清楚。在这里,我们表明氧化的 LDL 和淀粉样β通过 Toll 样受体 4 和 6 的异二聚体触发炎症信号。这种新鉴定的异二聚体的组装受清道夫受体 CD36 的信号调节,CD36 是这些不同配体的常见受体。我们的结果表明,CD36-TLR4-TLR6 的激活是动脉粥样硬化脂质和淀粉样β刺激无菌性炎症的共同分子机制,并提出了一种新的 TLR 异二聚体形成模型,该模型由共受体信号事件触发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8774/2809046/ddd3faf987a7/ukmss-28241-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索